New York, United States
Conflixis, founded in 2022 and headquartered in the United States, is revolutionizing the AI industry with its focus on streamlining conflicts of interest (COI) management in healthcare. The company stands by its slogan, "Conflicts of Interest in Healthcare, Solved." By replacing outdated and manual processes with intelligent automation, Conflixis enhances the speed, accuracy, and defensibility of COI disclosures, a critical and often overlooked component in healthcare administration.
The company recently secured a $4.20M Seed Round on 09 November 2024, attracting top-tier investors including Lerer Hippeau, Origin Ventures, SpringTime Ventures, Mark Ventures, and Crētiv Capital. This investment round provides Conflixis with a robust financial foundation to expand its offerings and solidify its positioning within the sector. Investors are particularly drawn to its innovative use of AI to address a persistent challenge in healthcare, indicating a strong potential for growth and scalability.
